- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Guezuraga quits as Positron CEO
Positron CEO and president RobertM. Guezuraga has left the company, the Houston-based developerof PET scanners announced this month. Gary B. Wood, the vendor'schairman, will assume Guezuraga's responsibilities on an interimbasis until a new CEO is found.
Positron CEO and president RobertM. Guezuraga has left the company, the Houston-based developerof PET scanners announced this month. Gary B. Wood, the vendor'schairman, will assume Guezuraga's responsibilities on an interimbasis until a new CEO is found.
Guezuraga had been a member of Positron's board of directorssince 1989 and its chief executive since 1990. He will continueto serve on Positron's board, the company said.
Positron has begun a search for a new chief executive and islooking for an individual with experience in marketing and acquisitions,according to the company.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
